跳至主要内容
临床试验/NCT06993662
NCT06993662已完成1 期

The Effectiveness and Efficacy of the Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective for Patients With Mental Health Disorders

Rakitzi, Stavroula1 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2025年6月2日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
107
试验地点
1
主要终点
The Greek verbal memory test

研究概览

简要总结

The combination of pharmacotherapy and individual cognitive behavioral therapy in a private practice.

详细描述

Reintegration into society and good functional outcome by people with mental health disorders is frequently the result of the combination of pharmacotherapy and individual cognitive behavioral psychotherapy. The effectiveness and efficacy of this combination of treatments under the recovery perspective by anxiety disorders, depressive disorders, PTSD, bipolar disorders, schizophrenia and psychotic disorders, by obsessive-compulsive disorders and by personality disorders presents the main goal of this research protocol. Recovery means that people learn through the trherapy to be responsible towards their own problems.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age 18-65,
  • •Diagnosis: anxiety disorders, depression, obsessive-compulsive disorders, PTSD, personality disorders, bipolar disorders, schizophrenia and psychotic disorders.

排除标准

  • •*Substance abuse and head injury.

研究组 & 干预措施

Group E

Experimental

The combination of pharmacotherapy (antipsychotics (clozapine and atypical antipsychotics)) , anxiolytics (Tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI)) and individual cognitive behavioral psychotherapy by schizophrenia and psychotic disorders.

20 patients

干预措施: Group E. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by schizophrenia and psychotic disorders (Combination Product)

Group C

Experimental

The combination of pharmacotherapy (anxiolytics (Tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI)) and individual cognitive behavioral psychotherapy by obsessive-compulsive disorder.

15 patients

干预措施: Group C. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by obsessive-compulsive disorder. (Combination Product)

Group F

Experimental

The combination of pharmacotherapy (antidepressants (SSRI, SNRI), anxiolytics (Tavor, clonotril, lexotanil) antipsychotics (clozapine and atypical antipsychotics)) and individual cognitive behavioral psychotherapy by personality disorders.

20 patients (2 narcistic personality disorder, 5 borderline personality disorder, 4 obsessive-compulsive disorder, 5 avoidant personality disorder, 4 depedent personality disorder)

干预措施: Group F.The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by personality disorders (Combination Product)

Group A

Experimental

The combination of pharmacotherapy (anxiolytics (Tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI)) and individual cognitive behavioral psychotherapy by anxiety disorders and depression.

20 patients

干预措施: Group A. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by anxiety disorders and depression. (Combination Product)

Group B

Experimental

The combination of pharmacotherapy (anxiolytics (Tavor, clonotril, lexotanil), antidepressants (SSRI, SNRI)) and individual cognitive behavioral psychotherapy by PTSD.

12 patients

干预措施: Group B. The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by PTSD (Combination Product)

Group D

Experimental

The combination of pharmacotherapy (anxiolytics ((Tavor, clonotril, lexotanil), antidperessants (SSRI, SNRI), mood stabilizers (Lithium, depakine) and antipsychotics (clozapine and atypical antipsychotics)) and individual cognitive behavioral psychotherapy by bipolar disorders.

15 patients

干预措施: Group D.The combination of pharmacotherapy and individual cognitive behavioral psychotherapy by bipolar disorder (Combination Product)

结局指标

主要结局

The Greek verbal memory test

时间窗: Follow-up up to 24 weeks

It measures oral verbal memory. Semantic. Sum of the 3 categories divided to 3. Minimum 0, maximum 40. high scores better.

The Clinical Global Impression Scale (CGI)

时间窗: Follow-up up to 24 weeks

It measures severity of illness. Minimum 0, Maximum 7, low scores better.

MCCB BACS symbol coding

时间窗: Preintervention

It measures speed of processing. Minimum 0, maximum 110, high scores better

MCCB BACS symbol coding

时间窗: Immediately after the intervention

It measures speed of processing. Minimum 0, maximum 110, high scores better

MCCB Wechsler memory scale-spatial span

时间窗: Preintervention

It measures non-verbal working memory. Minimum 0, maximum 32, high scores better, Summary of forward and backward total score.

MCCB Wechsler memory scale-spatial span

时间窗: Immediately after the intervention

It measures non-verbal working memory. Minimum 0, maximum 32, high scores better, Summary of forward and backward total score.

MCCB Neurospychological Assessment Battery (NAB)

时间窗: Preintervention

It measures reasoning and problem-solving. Minimum 0, maximum 26. high scores better

MCCB Neurospychological Assessment Battery (NAB)

时间窗: Immediately after the intervention

It measures reasoning and problem-solving. Minimum 0, maximum 26. high scores better

MCCB Brief visuospatial memory test

时间窗: Preintervention

It measures visual memory. Sum of Trial 1, 2, 3. Minimum 0, maximum 12. high scores better

MCCB Brief visuospatial memory test

时间窗: Immediately after the intervention

It measures visual memory. Sum of Trial 1, 2, 3. Minimum 0, maximum 12. high scores better

The Greek verbal memory test

时间窗: Preintervention

It measures oral verbal memory. Semantic. Sum of the 3 categories divided to 3. Minimum 0, maximum 40. high scores better.

The Greek verbal memory test

时间窗: Immediately after the intervention

It measures oral verbal memory. Semantic. Sum of the 3 categories divided to 3. Minimum 0, maximum 40. high scores better.

SCL-90-R

时间窗: Preintervention

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

SCL-90-R

时间窗: Immediately after the intervention

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

PANNS total

时间窗: Preintervention

It measures positive, negative symptoms and general psychopathology. Minimum 31, maximum 210. Low scores better

RAS-DS total

时间窗: Preintervention

It measures recovery. Minimum 0, maximum 152. High scores better.

PANNS total

时间窗: Immediately after the intervention

It measures positive, negative symptoms and general psychopathology. Minimum 31, maximum 210. Low scores better

WHODAS total

时间窗: Preintervention

It measures functional outcome. Minimum 0, maximum 100. low scores better.

WHODAS total

时间窗: Immediately after the intervention

It measures functional outcome. Minimum 0, maximum 100. low scores better.

RAS-DS total

时间窗: Immediately after the intervention

It measures recovery. Minimum 0, maximum 152. High scores better.

The Clinical Global Impression Scale (CGI)

时间窗: Preintervention

It measures severity of illness. Minimum 0, Maximum 7, low scores better.

The Clinical Global Impression Scale (CGI)

时间窗: Immediately after the intervention

It measures severity of illness. Minimum 0, Maximum 7, low scores better.

SRSDA

时间窗: Preintervention

It measures Depression. Minimum 0, maximum 14 or higher. Low scores better

SRSDA

时间窗: Immediately after the intervention

It measures Depression. Minimum 0, maximum 14 or higher. Low scores better

SRSDA B

时间窗: Preintervention

It measures Anxiety. Minimum 0, maximum 10 or higher. Low scores better

SRSDA B

时间窗: Immediately after the intervention

It measures Anxiety. Minimum 0, maximum 10 or higher. Low scores better

Hamilton Depression Scale

时间窗: Preintervention

It measures depression. Minimum 0, maximum 23. Low scores better.

Hamilton Depression Scale

时间窗: Immediately after the intervention

It measures depression. Minimum 0, maximum 23. Low scores better.

Montgomery and Asperg depression scale

时间窗: Preintervention

It measures depression. Minimum 0, maximum 60. Low scores better.

Montgomery and Asperg depression scale

时间窗: Immediately after the intervention

It measures depression. Minimum 0, maximum 60. Low scores better.

The Altman self-rating scale

时间窗: Preintervention

It measures mania. Minimum 0, maximum 6 or higher. Low scores better.

The Altman self-rating scale

时间窗: Immediately after the intervention

It measures mania. Minimum 0, maximum 6 or higher. Low scores better.

The Young mania rating scale

时间窗: Preintervention

It measures mania. Minimum 0, maximum 60. Low scores better

The Young mania rating scale

时间窗: Immediately after the intervention

It measures mania. Minimum 0, maximum 60. Low scores better

PSYRAT H

时间窗: Preintervention

It measures psychotic symptoms. Hallucinations. Minimum 0, maximum 24. Low scores better.

PSYRAT H

时间窗: Immediately after the intervention

It measures psychotic symptoms. Hallucinations. Minimum 0, maximum 24. Low scores better.

PSYRAT D

时间窗: Preintervention

It measures psychotic symptoms. Delusions. Minimum 0, maximum 44. Low scores better

PSYRAT D

时间窗: Immediately after the intervention

It measures psychotic symptoms. Delusions. Minimum 0, maximum 44. Low scores better

MCCB Wechsler memory scale-spatial span

时间窗: Follow-up up to 24 weeks

It measures non-verbal working memory. Minimum 0, maximum 32, high scores better, Summary of forward and backward total score.

MCCB Neurospychological Assessment Battery (NAB)

时间窗: Follow-up up to 24 weeks

It measures reasoning and problem-solving. Minimum 0, maximum 26. high scores better

MCCB Brief visuospatial memory test

时间窗: Follow-up up to 24 weeks

It measures visual memory. Sum of Trial 1, 2, 3. Minimum 0, maximum 12. high scores better

SCL-90-R

时间窗: Follow-up up to 24 weeks

It evaluates psychopathology. T\>60 means psychopathology. Low scores better

PANNS total

时间窗: Follow-up up to 24 weeks

It measures positive, negative symptoms and general psychopathology. Minimum 31, maximum 210. Low scores better

WHODAS total

时间窗: Follow-up up to 24 weeks

It measures functional outcome. Minimum 0, maximum 100. low scores better.

RAS-DS total

时间窗: Follow-up up to 24 weeks

It measures recovery. Minimum 0, maximum 152. High scores better.

SRSDA

时间窗: Follow-up up to 24 weeks

It measures Depression. Minimum 0, maximum 14 or higher. Low scores better

SRSDA B

时间窗: Follow-up up to 24 weeks

It measures Anxiety. Minimum 0, maximum 10 or higher. Low scores better

Hamilton Depression Scale

时间窗: Follow-up up to 24 weeks

It measures depression. Minimum 0, maximum 23. Low scores better.

Montgomery and Asperg depression scale

时间窗: Follow-up up to 24 weeks

It measures depression. Minimum 0, maximum 60. Low scores better.

The Altman self-rating scale

时间窗: Follow-up up to 24 weeks

It measures mania. Minimum 0, maximum 6 or higher. Low scores better.

The Young mania rating scale

时间窗: Follow-up up to 24 weeks

It measures mania. Minimum 0, maximum 60. Low scores better

PSYRAT H

时间窗: Follow-up up to 24 weeks

It measures psychotic symptoms. Hallucinations. Minimum 0, maximum 24. Low scores better.

PSYRAT D

时间窗: Follow-up up to 24 weeks

It measures psychotic symptoms. Delusions. Minimum 0, maximum 44. Low scores better

MCCB BACS symbol coding

时间窗: Follow-up up to 24 weeks

It measures speed of processing. Minimum 0, maximum 110, high scores better

次要结局

  • WAIS(Preintervention)

研究者

发起方
Rakitzi, Stavroula
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Stavroula Rakitzi

Dr. phil., Dipl.-Psych., Clinical psychologist and cognitive behavioral psychotherapist

Rakitzi, Stavroula

研究点 (1)

Loading locations...

相似试验